Skip to main content
. 2019 May 7;3(7):1283–1301. doi: 10.1210/js.2019-00096

Figure 1.

Figure 1.

Cardiometabolic effects of adjuvant endocrine therapy. Main outcomes and evidence sources for tamoxifen and aromatase inhibitors are presented. DXA, dual-energy X-ray absorptiometry; LDL, low density lipoprotein; Lp(a), lipoprotein(a); n, number; RCT, randomized control trial.